Issue 7, 2011

Carbocyclic 5′-nor “reverse” fleximers. Design, synthesis, and preliminary biological activity

Abstract

A series of 5′-nor carbocyclic “reverse” flexible nucleosides or “fleximers” have been designed wherein the nucleobase scaffold resembles a “split” purine as well as a substituted pyrimidine. This modification was employed to explore recognition by both purine and pyrimidine metabolizing enzymes. The synthesis of the carbocyclic fleximers and the results of their preliminary biological screening are described herein.

Graphical abstract: Carbocyclic 5′-nor “reverse” fleximers. Design, synthesis, and preliminary biological activity

Supplementary files

Article information

Article type
Concise Article
Submitted
31 Mar 2011
Accepted
25 Apr 2011
First published
19 May 2011

Med. Chem. Commun., 2011,2, 650-654

Carbocyclic 5′-nor “reverse” fleximers. Design, synthesis, and preliminary biological activity

S. C. Zimmermann, J. M. Sadler, G. Andrei, R. Snoeck, J. Balzarini and K. L. Seley-Radtke, Med. Chem. Commun., 2011, 2, 650 DOI: 10.1039/C1MD00094B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements